RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IFRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

InflaRx N.V. stock price down 0% on Wednesday
(Updated on Mar 27, 2024)

Sell candidate since Mar 21, 2024 PDF

No changes to the price of InflaRx N.V. stock on the last trading day (Wednesday, 27th Mar 2024). During the last trading day the stock fluctuated 5.26% from a day low at $1.52 to a day high of $1.60. The price has fallen in 4 of the last 10 days and is down by -2.53% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.70% during the next 3 months and, with a 90% probability hold a price between $1.29 and $1.74 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IFRX Signals & Forecast

Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". Some negative signals were issued as well, and these may have some influence on the near short-term development. The InflaRx N.V. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.58 and $1.60. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, March 05, 2024, and so far it has fallen -13.97%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for InflaRx N.V. stock

InflaRx N.V. finds support from accumulated volume at $1.51 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0800 between high and low, or 5.26%. For the last week, the stock has had daily average volatility of 9.19%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IFRX) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect InflaRx N.V. to open at $1.55, and during the day (based on 14 day Average True Range), to move between $1.41 and $1.67, which gives a possible trading interval of +/-$0.134 (+/-8.70%) up or down from last closing price. If InflaRx N.V. takes out the full calculated possible swing range there will be an estimated 17.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.51 (1.95%) than the resistance at $1.65 (7.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is InflaRx N.V. stock A Buy?

InflaRx N.V. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.686 Sell Candidate Unchanged

Predicted Opening Price for InflaRx N.V. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$1.55 ( 0.87%) $1.54

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IFRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.63 6.06 %
R2 1.60 4.08 %
R1 1.58 2.85 %
Current price: 1.54
Support S1 1.52 -1.12 %
S2 1.50 -2.34 %
S3 1.47 -4.33 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.83 18.83 %
R2 1.75 13.64 %
R1 1.65 7.14 %
Current price 1.54
Support S1 1.51 -1.95%
S2 1.50 -2.60%
S3 1.47 -4.55%

FAQ

What is the symbol for InflaRx N.V. Stock and on which exchange is it traded?
The symbol for InflaRx N.V. is IFRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell InflaRx N.V. Stock?
InflaRx N.V. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy InflaRx N.V. Stock?
InflaRx N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy InflaRx N.V. Stock.

What's the current price of InflaRx N.V. Stock?
As of the end of day on the 2024-03-27, the price of an InflaRx N.V. (IFRX) share was $1.54.

What is the 52-week high and low for InflaRx N.V. Stock?
The 52-week high for InflaRx N.V. Stock is $7.25 and the 52-week low is $1.14.

What is the market capitalization of InflaRx N.V. Stock?
As of the 2024-03-27, the market capitalization of InflaRx N.V. is 90.68M.

When is the next earnings date for InflaRx N.V.?
The upcoming earnings date for InflaRx N.V. is May 09, 2024.
Click to get the best stock tips daily for free!

About InflaRx N.V.

InflaRx N.V. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c... IFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT